Tenzing Acquisition in an 8-K filing today said shareholders voted to merge with pharmaceuticals company Reviva. The deal gives the combined company a valuation of $119 million. Read more.
Related Posts
Good Works Announces Automatic Unit Separation
This is a mandatory and automatic separation, and no action is required by the shareholders.
Roth CH II Stock and Warrants to Begin Separate Trading
The SPAC plans to target the business services, consumer, healthcare, technology, wellness or sustainability sectors.
Redemptions Erase Nearly Half of Ace Global Business Acquisition’s Trust on Extension Vote
Redemptions of 22.6 million shares left $25.2 million in trust.
Enphys Acquisition Inks LOI with Latin American Biofuels Company
Enphys raised $345 million in an October 2021 IPO with plans to target businesses predominantly operating in Ibero-America and whose strategy is aligned with energy transition and sustainability themes, renewable energy in particular.